ABSTRACT
INTRODUCTION
Recently, we reported the cloning and sequencing of nine members of the human tRNA
Val gene family and summarized some of their functional properties in vitro (1 -3) . Pirtle and coworkers characterized two human gene clusters, X hPTV5 (4) and X hVKV7 (5) , which contain, apart from genes for other tRNA species, one and two tRNA
Val genes, respectively. One of the two tRNA
Val genes in the latter clone seems to be identical with a tRNA Val gene also described by us except for some point mutations in its 5' flanking region. Thus, there is information available about altogether eleven human tRNA
Val genes. This is at least one half of their total number, since human tRNA multigene families are estimated to contain about 20 members each (6) .
The composition of this gene family, as elucidated so far, provides some surprise, because considerable sequence variability is detected among its members. Three genes, those in clones pHtVl (1) , pHtV6, and pHtV8 (3), the latter of which corresponds to the tRNA Val AAC gene in clone X hVKV7 (5), encode the major tRNA Val [AC , and two genes, one in clone pHtV3 (1) and one in clone X hVKV7 (5) , encode the minor tRNA Val CAC from human placenta. Hence, only five of the eleven human tRNA
Val genes characterized so far code for one of the known functional valine-specific isoacceptors (7) . The other six genes exhibit sequence differences in the region coding for the mature tRNA.
In three cases, i. e., the tRNA Val genes in clones pHtV5, pHtV7 (3) and X hPTV5 (4), the mutations do not seem to impair the structure and function of the corresponding tRNA products, since conserved, invariable nucleotides are not concerned and since the formation of a normal two-and threedimensional tRNA shape still appears to be possible. In vitro, these three genes are transcribed and processed to give products of the size and the sequence expected for a mature tRNA (3, 4) . The name 'allogenes' has been proposed for such genes which may be functional in vivo and code for yet uncharacterized minor isoacceptors (8) . It should be mentioned that a third valineaccepting tRNA species is known to exist in human placenta which has not been purified and sequenced so far (9) .
The three remaining genes have to be regarded as pseudogenes. Although they are functional in the sense that they are transcribed in vitro, they do not lead to the formation of mature tRNAs. In two cases, i. e., the genes in clones pHtV4 and pHtV9 (2, 3) , the respective mutations presumably cause crippled secondary and tertiary structures of the corresponding transcripts. Consequently, these are not processed at all, because maturation enzymes, which obviously depend on a correct tertiary structure of the mature tRNA domain (10) , do not accept them as substrates. As for the third pseudogene, the one in clone pHtV2, the mutations do not affect the secondary or tertiary structure of its RNA products. The primary transcript undergoes a certain degree of maturation and the 5' end is correctly cleaved, however, the 3' end is not correctly processed and the CCA terminus can not be added (3) .
This remarkable structural and functional diversity within a human tRNA gene family, showing redundancy as well as variety of information, prompts the question what may be its significance for the organism. Moreover, the knowledge of eleven tRNA Val genes is a unique prerequisite for studying the expression of this tRNA gene family in vivo. Interesting issues in this context may concern: a) the expression and regulation of the gene family in general or of its single representatives in particular and how they contribute to maintain or alter the pool of mature tRNAs in different cells, tissues or differentiation stages; b) the role of the variant genes also with respect to the question of developmental stage or tissue specificity, as there is already evidence for the occurrence of variant tRNAs in highly specialized organs as, e. g., the silkgland of Bombyx ntori; in the case of the most extensively studied example, tRNA AU , this is due to the activation of a tissue-specific tRNA gene (11) Val CAC with at least three and two genes coding for them, respectively. Hence, the presence of a certain tRNA in cells or tissues provides no evidence for the expression of one distinct gene out of a group of genes coding for the same isoacceptor. The activity of a single gene locus can be demonstrated if, e. g., tRNA precursors deriving from it are detected. As the flanking regions of tRNA genes mostly differ considerably (for the tRNA
Val genes compare refs. 3 -5) , the knowledge of the 5' leader sequence of a precursor should suffice to assign the latter to a single tRNA gene locus. However, tRNA precursors are certainly subject to a rapid turnover by the processing enzymes and presumably occur in only very low concentrations. Consequently, any experimental technique used must be able to detect very small amounts of pre-tRNAs in the presence of a high excess of mature tRNA.
We found that primer extension meets this necessity. By applying this technique we could demonstrate the activity of several single tRNA Val gene loci in HeLa cells and human placenta. Among these, there are genes, variant genes and pseudogenes which are already well characterized (1 -5) as well as yet unknown tRNA
Val genes. Thus, this allowed for the first time to get an insight into the expression of a human tRNA gene family in vivo.
MATERIALS AND METHODS Enzymes and Chemicals
T4 polynucleotide kinase was purchased from NEN. AMV reverse transcriptase, salmon sperm DNA, and dideoxynucleoside triphosphates were from Boehringer, Mannheim. (y-32 P)-ATP with a specific activity of 110 Tbq/mmol was obtained from Amersham. Guanidinium rhodanide was from Fluka and DEAE cellulose from Whatman. All other chemicals were obtained from Fluka, Merck, Serva, or Sigma. Oligodeoxyribonucleotide primers for reverse transcription were synthesized using the DNA synthesizer 2000 from Applied Biosystems. Pure tRNA^^c from rabbit liver was prepared in this laboratory (12) .
Isolation of low molecular weight RNA RNA was isolated by lysis of a HeLa cell pellet or of placenta tissue in the presence of guanidinium rhodanide according to Maniatis et al. (13) . The high molecular weight fraction was removed from the RNA preparations by DEAE cellulose chromatography essentially as described by Roe (14) . The low molecular weight fraction contains mainly 5S rRNA and tRNA.
5'-labelling of primer oligonucleotides 25 pmoles of the primer, 500 jiCi of (7- 32 P)-ATP and 5 units of T4 polynucleotide kinase were incubated for 30 min at 37°C in 10 n\ reaction buffer (100 mM TrisHCl, pH 8.0; 20 mM MgCl 2 ; 3.3 mM spermin; 33 mM /3-mercaptoethanol). The 15-mer or 20-mer oligodeoxyribonucleotides (Fig. 1) were separated from shorter oligomers and from unincorporated radioactivity on 20% polyacrylamide/8 M urea gels.
Primer extension
Primer extension reactions on a preparative scale were done as follows: 60 to 150 /tg low molecular weight RNA from Hela cells or from human placenta and 3x 10 7 to 10 8 cpm (10 to 30 ng; 2 to 6 pmoles) 5' labelled primer oligonucleotide were precipitated with 0.1 vol 2 M sodium acetate, pH 5.2 and 2 vol of ethanol. For primer hybridization, the precipitated nucleic acids were dissolved in 100 /tl buffer I (10 mM TrisHCl, pH 8.3; 250 mM NaCl; 1 mM EDTA), heated to 95°C for 10 min, cooled on ice for 5 min and incubated at room temperature for 20 min. To stop the elongation reaction, the samples were heated to 95 °C for 5 min. After ethanol preciptation, the nucleic acids were dissolved in 50 /tl loading buffer (90% formamide, 10 mM EDTA, 0.1 % bromophenol blue, 0.1 % xylene cyanol), denatured for 10 min at 95°C, and cooled on ice for 2 min. The short elongation products obtained by priming with oligonucleotide Val-6/20 ( Fig. 1) were purified on 25% polyacrylamide/6 M urea gels (dimensions: 880x240x0.35 mm; slot width: 4 cm; 45 h at 3000 V and 20 mA). Longer reverse transcripts synthesized after priming with Val-22/41 (Fig. 1) were separated on 20% polyacrylamide/8 M urea gels (dimensions: 600x200x0.35 mm; slot width: 4 cm; 10 h at 2500 V and 17 mA). Following electrophoresis, the gels were exposed for different time intervals on preflashed Fuji RX X-ray film in the presence of an intensifying screen.
Using the autoradiograms, reverse transcription products of interest were localized, excised from the gel, and eluted by diffusion into 200 /d of 10 mM Tris-HCl, 1 mM EDTA, pH 7.5. They were precipitated with ethanol in the presence of 10 /tg salmon sperm DNA, redissolved in 32 y\ of sterile H 2 O and used for sequencing by the method of Maxam and Gilbert (15) .
Control reactions on an analytical scale contained 1 ng purified rabbit liver tRNA Val , poly(A) as a carrier for the precipitation (20 /tg), 3 U of reverse transcriptase, and 10 6 cpm of labelled primer oligonucleotide in 10 /tl of buffer I and 15 /tl of buffer II (see above).
DNA sequencing
Chemical sequencing reactions were performed essentially as described by Maxam and Gilbert (15) . However, incubation times were varied in the following manner to achieve sufficient cleavage of the short DNA molecules analyzed: G-reaction, 10 min/20°C; A+G-reaction, 20 min/20°C; C + T-reaction and C-reaction, 1 h/37°C. Sequencing gels contained 15% or 20% polyacrylamide and 8 M urea.
RESULTS

Design of suitable primers for primer extension with pretRNAs Va) as templates
For most primer extension experiments we used the pentadecadeoxyribonucleotide Val-6/20 ( Val genes examined in our laboratory occurs between positions -2 and -9, at least in vitro (3) . This leads to primer extension products 20 to 30 nucleotides long which can be separated from each other by electrophoresis on long 25% polyacrylamide/6 M urea gels. A primer length of fifteen nucleotides ensures sufficient specifity of hybridization with the tRNA Val or pre-tRNA Va) templates; any RNA or gene sequence examined using the NTH GenBank data showed less than 10 nucleotides homology with this oligonucleotide. Hence, only inefficient hybridization to other RNAs that could impair the specificity of the primer extension reaction is expected. The fact that the region of complementarity between the oligonucleotide and tRNA
Val starts at nucleotide 6 of the mature tRNA and not at nucleotide 1 was intended as an additional control for the specificity of the hybridization. In mammalian tRNAs (or tRNA genes), the sequence motif 5 Some experiments were done in order to visualize mutations in the DHU-arm of variant tRNA
Val species. The primer used in this case was the ikosadeoxyribonucleotide Val-22/41 which hybridizes to the anticodon stem and loop and part of the DHUstem (Fig. 1) . Vl1 genes corresponding to clones pHtVl (= 1) to pHtV9 (= 9). cDNAs of prc-tRNAs transcribed from pHtV6-and pHtV7-related genes, respectively, were not detected. The cDNAs of pre-tRNAs of the gene related to the tRNA™ CAC gene in clone X hVKV7 (5) and of a yet unknown tRNA VlJ gene are labelled with 'a' and 'b', respectively. '*' marks additional, minor initiation sites, and the brace signifies that the pre-tRNA which gave rise to this cDNA may have been transcribed either from the gene corresponding to pHtV4 or from that related to the tRNA Vll CAC gene in clone X hVKV7 (initiation at -3, compare Table 1 ). Expression of the tRNA Vl) gene corresponding to that in clone X hPTV5 was detected in an experiment with the primer Val-22/41 (not shown). Note that bands 4* (H) and 5 (P) in the right panel are not identical in spite of their almost identical electrophoretic mobility. Val in sufficient amounts to determine their nucleotide sequences according to the method of Maxam and Gilbert (15) . For this purpose, low molecular weight RNA from He La cells or from human placenta was subjected to primer extension (preparative scale) with the oligonucleotide Val-6/20. In parallel, a control reaction (analytical scale) with purified tRNA
Preparative primer extension
Val from rabbit liver was carried out. Conditions for the assay and the electrophoretic separation of the elongation products are described in Materials and Methods. Fig. 2 shows an autoradiogram produced in the course of such an experiment. In the control reaction the longest reverse transcription product is the one which is obtained upon primer elongation with mature tRNA Val as a template (Fig. 2, m) . In the assays with unfractionated tRNA preparations (Fig. 2 , lanes H and P) there are additional, longer cDNAs with lower electrophoretic mobility which derive from tRNA precursor molecules. The separation achieved by the 88 cm long 25 % polyacrylamide/6 M urea gel is not only according to the length, but also partly according to the nucleotide composition of the primer extension products. Therefore, a considerable number of precursor-derived products is dissolved in lanes H and P. The number of bands which are clearly distinguishable from each other are about thirty in each of the two RNA preparations.
Primer extension products deriving from precursors as well as from mature tRNA
Val were excised, eluted from the gel, and the radioactivity was determined in a liquid scintillation counter. If one assumes that the yield of reverse transcript is directly proportional to the amount of the corresponding template, the ratio of the mature tRNA to pre-tRNAs in an RNA preparation analyzed by primer extension can be calculated from the respective 32 P counts. Usually about 3.5 X10 7 and 5x 10 7 cpm were incorporated into the cDNAs deriving from mature tRNA in the case of HeLa cell and placenta RNA, respectively, whereas the more or less prominent products derived from precursor molecules ranged from several thousand to about 6x 10 4 cpm. Therefore we conclude that in HeLa cells or placenta tissue the mature tRNA
Val is present in an at least 500-fold excess over the corresponding pre-tRNAs Val .
Eluted cDNAs containing more than 4000 cpm were subjected to nucleotide sequence analysis by the chemical cleavage method of Maxam and Gilbert (15) . In preliminary experiments, primer extension products obtained by reverse transcription of purified rabbit liver tRNA V(U were subjected to nucleotide sequencing (not shown). These cDNAs showed exactly the sequences expected, i. e., they were complementary to nucleotides 1 to 5 of tRNA
Val with Val-6/20 as a primer and to nucleotides 1 to 21 with Val-22/41 as a primer (apart from the 15 and 20 nucleotides, respectively, of the primers themselves). In the latter case, modified nucleotides D and \p were transcribed into A. These results indicated that faithfully transcribed cDNAs were to be expected, too, with pre-tRNAs as templates. Genes for the known tRNA Val isoacceptors that are expressed in vivo Fig. 3 shows a selection of autoradiograms obtained from the primer extension experiments described above. They display the nucleotide sequences of the 3' ends of the cDNAs which enabled us to deduce the 5' leader sequences of precursor tRNAs occurring in vivo that had been the templates for reverse transcription. Some of the products identified could be assigned unequivocally to tRNA
Val genes that have already been cloned and characterized by us (1 -3) as well as by Craig et al. (5) and by Shortridge et al. (4) . These genes are also indicated in Fig. 2 3 ' in unfractionated tRNA preparations from Hela cells or placenta. These are leader sequences that are expected for transcription products of the three pseudogenes represented by clones pHtV2, pHtV4, and pHtV9, respectively. This means that genes corresponding to any of the tRNA Val pseudogenes characterized so far are transcribed in vivo, namely pHtV2-and pHtV4-related genes in HeLa cells as well as pHtV4-and pHtV9-related genes in placenta. The pre-tRNAs of the cellular genes corresponding to pHtV4 and pHtV9 are predominant species in the respective cell types studied. Table 1 summarizes the available data concerning the expression of tRNA
Val genes in the two cell types examined and gives an evaluation for the abundance of the corresponding pretRNAs. Among the active genes there are representatives of any of the three classes of genes described by Thomann et al. (3) : a) genes for the two known tRNA Val isoacceptors identified in human placenta (7); b) gene variants, also termed 'allogenes' according to Leung et al. (8) , which exhibit sequence alterations as compared to conventional genes, but which may nevertheless code for yet unknown functional, minor tRNA isoacceptors; c) pseudogenes, which produce rather stable pre-tRNAs and apparently do not give rise to mature tRNAs (3).
Yet unknown tRNA
Val genes that are transcribed in vivo
Apart from the pre-tRNAs transcribed from already characterized tRNA Val genes, some precursors occur in HeLa cell and placenta tRNA preparations that obviously derive from so far unknown tRNA
Val genes. In one case, the 5' leader sequence could be determined: it is 5 'ACCGCCUG... 3 ' (Fig. 3) . However, in spite of our rather rigorous electrophoresis conditions there still existed the problem that certain cDNAs could not be sufficiently separated on the gel and therefore contaminated each other. Hence, the 5' leader sequences of the corresponding pre-tRNAs could not be determined unequivocally. Nevertheless, since they all contain a 5 '...GUUUC... 3 ' motif which was clearly distinguishable, they certainly are pre-tRNAs VaI .
The estimated number of the so far unknown tRNA VaI genes transcribed in vivo may be up to four. Therefore, together with the members of the tRNA Val gene family active in vivo already mentioned above, whose number amounts to nine, up to thirteen tRNA
Val genes, allogenes, and pseudogenes appear to be transcribed in vivo. This means that, together with those genes whose expression in vivo could not be demonstrated, namely the pHtV6-and pHtV7-related genes, the tRNA Val gene family contains at least fifteen independent members.
Traces of other pre-tRNAs were also detected by the primer extension experiments described. As judged by the sequences Tabl* 1. In vivo expression of husmn tRNA" 1 ganes.
Clone nue (Refs.)
pHtVl (1) pHtV2 (1) pHtVJ (1) pHtV4 (2) pHtV5 (3) pHtV6 (3) pHtV7 (3) pBtVS (3) pHtV9 ( Clone names and corresponding references of all sequenced tRNA Vtl genes are given on the left. Flanking sequences of the non-coding, tRNA-like strands are shown in capital letters, 5' sequences of the structural genes in small letters. Arrowheads identify the transcription initiation sites of pre-tRNAs as determined by isolation and sequencing of the respective cDNAs in those cases where expression in vivo has been observed. As for the genes corresponding to those in clones pHtV 1, pHtV4, and perhaps also in X hVKV7 (arrowhead in parentheses), more than one initiation site has been detected. H = pre-tRNAs found in HeLa cells; P = pre-tRNAs found in placenta. ++ =30000to60000 cpm, + = 4000 to 30 000 cpm per cDNA band; -= not found in the respective cell type. The sequence of the 5' flanking region and of the 5' terminus of a putative, yet unknown tRNA Vl1 gene is presented at the bottom.
corresponding to their mature 5' ends they were not transcribed from tRNA Val genes. However, they only represent a small minority of the products and, furthermore, the corresponding cDNAs show only little radioactive incorporation. This demonstrates the specificity of the method of primer extension, leading to inefficient elongation of the tRNA Val -derived primer with templates other than pre-tRNAs Val or tRNA Val .
Transcription initiation sites in vivo
In vitro, any of the nine human tRNA Val genes examined by Thomann et al. (3) had more than one site for the initiation of transcription. As we show here, the initiation sites in vivo correlate with those found in vitro following a simple rule: The initiation site which is the most intensive in vitro is found in the precursor occurring in vivo (Table 1) . Interestingly, in HeLa cells there are obviously three pre-tRNAs that may derive from the pHtV4-related cellular gene. They have the 5' terminal sequences 5 GCGUGUGGUUUC... 3 ', 5 GUGUGGUUUC... 3 ', and 5 'GUGGUUUC... 3 '. Therefore, in the case of this gene initiation in vivo appears to occur at positions -7, -5, and -3 in exact agreement with the situation in vitro where initiation was also demonstrated to occur at these three sites (3) . Initiation at position -5 is most frequent both in vitro and in vivo. Also, the gene corresponding to pHtVl has two initiation sites in HeLa cells: -4 and -7 (see above). Finally, the precursor with the 5' terminus 5 'GUGGUUUC... 3 ' may also derive from the tRNA Val CAC gene represented by clone X hVKV7 (Table 1) which would mean that this gene, too, possibly has more than one initiation site in vivo. These results indicate that the finding of multiple initiation sites is not an in vitro artifact. A certain flexibility in the choice of the transcription initiation site seems to be a characteristic feature of RNA polymerase HI.
DISCUSSION
So far, there is only limited information about the expression of tRNA gene families of higher eukaryotes in vivo. A major obstacle for studying this subject is the characteristic redundancy of genetic information for a given tRNA species. The expression of a single gene or of several members out of a group of genes coding for the same isoacceptor therefore can not easily be monitored, and there are only a few examples where this was indeed possible. Cytogenetic studies of chromosomal deletion mutants carried out at salivary gland polytene chromosomes provided evidence for the expression of tRNA V(d gene clusters in D. melanogaster (17) . In yeast (18) and in C. elegans (19) the in vivo expression of tRNA T y r and tRNA Tl ? genes, respectively, has been studied via natural suppressor mutants. Neither of these methods, however, can be used in the case of vertebrates. Here, a possible strategy is to demonstrate the activity of a tRNA gene by identifying its primary transcripts in the RNA population of a certain cell type or tissue.
Under these aspects it is a breakthrough that primer extension has been proven to detect individual pre-tRNA species and therefore can reveal the activity of single tRNA gene loci in cultured cells or tissues. This had not necessarily to be expected, since there are conflicting data concerning the feasibility of primer extension with tRNA templates. The method was successfully used by Dingermann and Nerke (20) to investigate tRNA gene expression in yeast, whereas another group reported difficulties especially with modified nucleotides as m'A and wyeosine (21) . Recently primer extension has been applied to identify a developmentally regulated tRNA Val gene in Dictyostelium discoideum (22) and to determine the steady-state levels of unspliced precursors produced by oocyte and somatic tRNA 7ĝ enes in X. laevis (23) . We found that reverse transcription of human tRNA VlU and its precursors indeed yields faithfully transcribed cDNA products. It is certainly important that there are no highly modified nucleotides in that part of the pre-tRNAs
Val and tRNAs Val which functions as the template for primer extension. In any such case this technique is an accurate, reproducible, and extremely sensitive method to study tRNA gene expression in vivo, detecting minimal amounts of precursor against a high, i. e. 500-to several 1000-fold background of mature tRNA.
In the course of our experiments we were able to demonstrate the activity of several members of the human tRNA Val gene family in Hela cells and human placenta. It was expected that among them there are genes for the known tRNA
Val isoacceptor species isolated from human placenta (9) . Indeed, two genes for the major tRNA^'^c are expressed: the cellular genes corresponding to those in pHtVl and pHtV8 (1, 3) , the latter of which is identical with the tRNA genes in clones pHtV3 (1) and X hVKV7 (5) . An activity of the gene corresponding to clone pHtV6 (3) which also codes for tRNA^^c could not be detected. There are several possible reasons for this fact: a) The gene is active, but its precursors belong to those whose corresponding cDNAs could not sufficiently be purified to yield unambiguous data upon nucleotide sequencing. In this case, improved purification methods should reveal an expression of these genes in vivo.
b) The gene is silent and does not contribute to the pool of mature tRNAs
Val , at least not in HeLa cells or in placenta. c) The gene is active, but the concentration of the corresponding precursors is still too low to be detected even by the sensitive method of primer extension.
In principle, there are two processes that control pre-tRNA steady state concentrations in cells: the transcriptional activity of tRNA genes and the velocity of pre-tRNA maturation. pHtV6 is a clone with average transcriptional activity, but its primary transcripts are very rapidly processed in vitro (3) . If their maturation occurs as rapidly in vivo, this may be the reason for a low precursor level.
So far there is no evidence that in vitro assays faithfully reproduce the expressional properties of tRNA genes in vivo. Recent results rather indicate that tRNA gene activity in organisms follows more complex rules than data obtained by in vitro experiments suggest. For example, the tRNA Tyr genes of C. elegans are obviously controlled in a developmental stageor tissue-specific manner (19) . It is well established that tRNA pools adapt to protein synthesis requirements in highly differentiated cells (24, 25) . Regulation phenomena like those observed in the nematode may be functional in other organisms, too, and may be involved in that adaptation by keeping an appropriate number of genes active to maintain exactly the concentration of a tRNA needed under certain circumstances. Therefore, tissue-specific factors may also be responsible for a low expression level or even inactivity of the pHtV6-related and other silent genes (see below) in placenta and may activate them in other tissues.
Those tRNAs for which a tissue-or stage-specific occurrence has clearly been shown are all variant isoacceptors as, e. g., the silkgland-specific tRNA^ and tRNA^ of B. mori (26, 27) , the bovine lens-specific tRNA Phe (28) , and the stage-specific tRNA 1 "^ genes of X. laevis (23) . The most extensively studied example is that of the B. mori tRNA^; here, a sequence element in the 5' flanking region of the corresponding variant gene is responsible for an expression restricted to the silkgland (11) . For D. melanogaster, variant tRNA genes have also been well characterized and termed 'allogenes'. Although they are often more efficiently transcribed in vitro than conventional genes (8) , an activity in vivo has not been detected so far (17) . These data suggest that variant tRNA genes in general might be candidates for tissue-specifically regulated genes.
Although the two known valine-accepting tRNAs already mentioned suffice to read all four valine codons, at least one more tRNA VaI species obviously exists in human placenta (9) which has not yet been purified and sequenced. There is the possibility that this species differs from the other two only by die degree of nucleotide modification. On the other hand it is not unlikely that one of the human tRNA Vtl allogenes may code for it. Indeed, tRNA
Val genes corresponding to those in clones pHtV5 and X hPTV5 were shown to be expressed in placenta. Which of them gives rise to the third tRNA Val can only be elucidated by isolation and sequencing of the corresponding isoacceptor.
Since, as already mentioned the known allogenes of D. melanogaster could not be shown to be active in vivo (17) and since variant tRNAs may be restricted to highly specialized tissues (26) (27) (28) or certain developmental stages (22, 23) , this readily detectable activity of two tRNA Val allogenes is a surprise. It may mean either that allogenes of the human tRNA Val gene family can be constitutively expressed or that placenta is one of those specialized tissues that require the expression of variant tRNA genes.
As for the pHtV7-related, third tRNA VaI allogene, whose activity in vivo we also wanted to show, a reverse transcript derived from a corresponding pre-tRNA was not found among the sequenced cDNAs. Since the precursor could have escaped detection for one of the reasons discussed above, we intended to demonstrate the presence of the variant tRNA itself because of its presumably higher concentration as compared to that of its precursor. We utilized an oligonucleotide primer for reverse transcription that has 100% complementarity with the possible pHtV7-related tRNA Val but which exhibits two mismatches causing inefficient priming when hybridizing to the conventional tRNAs Val , since the region of homology spans that part of the T arm where the tRNA of this allogene deviates from the known tRNAs Val (3) . In several experiments we could not detect the occurrence of the respective variant tRNA in placenta but we could not completely rule out its presence in HeLa cells. These results may mean that the cellular counterpart of the pHtV7 gene is not principally inactive but that it is possibly a candidate for a differentially regulated tRNA gene.
Our results demonstrate with remarkable clarity different pretRNA Val populations in HeLa cells and placenta. It appears unlikely that these differences are caused by different levels of processing enzymes, since certain pre-tRNAs are absent or low in one of both cell type. Our data indicate that primer extension may be a powerful general approach for studying stage-or tissuespecific tRNA gene expression. Detailed statements about differential tRNA gene expression as presented here are preferentially feasible in those cases, where the genes and the respective flanking sequences for most or all members of a tRNA isoacceptor family are known and characterized by in vitro studies, and if the 5' leaders of individual pre-tRNAs are so different that the sequences between the mature 5' end and the transcription start points are unique.
Kahnt et al. (2) and Thomann et al. (3) have described three tRNA Val pseudogenes, those in clones pHtV2, pHtV4, and pHtV9. Since neither of them has defects in the internal promoter boxes, they are transcribed in cell-free transcription systems, however, they do not produce mature tRNAs. The primary transcripts of pHtV4 and pHtV9 are not processed at all; pHtV2-derived transcripts are correctly processed at their 5' ends whereas at the 3' end the precursor is cut 3 or 4 nucleotides downstream from the mature tRNA domain and, consequently, the CCA terminus is not added to this immature tRNA.
Considering the transcriptional activity of the pseudogenes in vitro, it was particularly interesting to find out whether they are also active in vivo. Indeed, this is the case for each of the three pseudogenes. It is one of the unexpected surprises of this study that their transcripts appear to accumulate and to be prominent species within the pre-tRNA population. This provokes the question what the significance of these transcripts may be in vivo. Are they produced in order to serve some yet unknown function as suggested, e. g., by Zasloff et al. (29) ? According to their model, unprocessed or slowly processed tRNA precursors which can not enter the cytoplasm might serve as a feedback signal to sense the transcriptional output of tRNA gene families. Only further experiments can bring an answer to these and other open questions concerning tRNA gene families and their expression.
